Our promise: to save lives and improve quality of life.

Our ability to innovate and deliver life-saving medicines for patients has earned us a reputation for always putting patients first. We are driven by our promise.

Find our more about our company

Careers at CSL Behring – Make a difference with your work!Find our more about careers →

CSL Behring News

CSL Behring News

Logo Alpha1 Science Awards

Alpha1 Science Awards

Award winners in 2025 announced at the Annual Meeting of the German Respiratory Society

10 Apr 2025
Visit Minister Kaweh Mansoori at M600

State visit by Minister Kaweh Mansoori

Marburg makes itself strong for business, research and the future

18 Mar 2025
illuminated castle Marburg

CSL Marburg sets an example on Rare Diseases Day

Press conference in the new plasma center and castle illumination

05 Mar 2025
group of participants

A Promising Start to the Future

We are delighted to welcome the eight new participants of the Re-Start Plus program at CSL Behring in Marburg!

21 Feb 2025
group of people discussing

Future of Maintenance

At the M2U #FutureDay 2025 in Marburg, experts jointly developed groundbreaking ideas for the maintenance industry.

18 Feb 2025
HY Results 25 graphic

Half Year Results 24/25

CSL reported net profit after tax of $2.04 billion in the first half of Fiscal Year 24/25.

12 Feb 2025
Christian Wieszner

Wieszner joins CSL Behring GmbH management

Christian Wieszner is new second managing director of CSL Behring GmbH in Marburg

07 Jan 2025
Dr. Martin Vey

Change in Management at CSL Innovation GmbH

Martin Vey succeeds Lars Grönke

06 Jan 2025
(from left to right) Dr. Lars Grönke (Managing Director of CSL Innovation), Lord Mayor Dr. Thomas Spies, University President Prof. Dr. Thomas Nauss and Dr. Martin Egger (Managing Director of site operator Pharmaserv and Infrareal Holding) jointly presented the previous and planned collaboration for a strong and sustainable Marburg site. (Photos: Stefanie Ingwersen, City of Marburg)

Marburg: a strong location

What the city, university and pharmaceutical companies are doing together

28 Nov 2024
Next